No.1 Probiotic for healthcare professionals

New research has shown that Symprove is the probiotic most recommended by gastroenterologists, dietitians and GPs.1* Why? Because it's proven in randomised controlled trials at leading institutions, and 92% of people report a positive difference in real-world evidence.2-5

Rated most evidence-based probiotic by UK dietitians

Our unique water-based solution

  • ARRIVE: Fermented Formulated with at least 10 billion CFUs per 70 ml serving.† Designed to deliver live, metabolically active bacteria at the point of consumption.
  • SURVIVE: 99.3% of live bacteria consumed are shown to pass through the stomach in under 10 minutes and stay alive throughout the gastrointestinal transit.6,9
  • THRIVE: Symprove's bacteria produce key metabolites, shift bacterial diversity, and induce an anti-inflammatory effect. 9-14

Trial Symprove

Proud partners

Recommended by clinical and scientific experts

Symprove is different from other probiotics because it is water-based, which means it limits exposure to gastric juices and digestive enzymes

Professor Simon Gaisford

Head of Pharmaceutics at UCL School of Pharmacy

In a world where there are many claims about gut health (with good evidence!), I’m so enthused by Symprove's research, and what we are seeing from the results.

Laura Tilt

Registered Dietitian

In order to be effective, probiotics need to 'arrive, survive and thrive'

Dr Sarah Jarvis MBE

Medical broadcaster, practicing GP and clinical consultant for patient.info

92% of people report a difference with Symprove over 3 months and we offer healthcare professionals a free trial to see for themselves

Imogen Wolsey

In-house Dietitian, Symprove

Symprove is proven in rigorous, double-blind, randomised controlled trials, with in-vitro studies demonstrating physiological and microbiological effects



Professor Ingvar Bjarnason

Consultant gastroenterologist, King's College Hospital, London

Educational resources

CPD

Expert articles

Webinars

Here's the latest...

  1. Data on file, 2024.
  2. Sisson G, et al. Aliment Pharmacol Ther 2014;40(1):51–62. 
  3. Kvasnovsky CL, et al. Inflammopharmcology 2017; doi: 10.1007/s10787-017-0363-y.
  4. Bjarnason I, et al. Inflammopharmacology 2019;27(3):465–473.
  5. Rudland S, et al. Journal of Primary Care and General Practice 2021:4(4).
  6. Kullen MJ, 1999   
  7. Fredua-Agyeman, 2015  
  8. Moens, 2019  
  9. Ghyselinck, 2020  
  10. Ghyselinck, 2021  
  11. Hatton, 2026  
  12. Fredua-Agyeman, 2017  
  13. Dodoo, 2019 
  14. Dodoo, 2025  

*Based on external survey (n=432 healthcare professionals), conducted and independently analysed by specialist research agency, 2024. Validated in 2026 (n=438 healthcare professionals).

†Fermented to a level of at least 10 billion CFUs per 70 ml and proven to deliver metabolically active bacteria at least until the expiration date

‡Offer valid for healthcare professionals who have not previously received a free Symprove trial.